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Abstract
Background: Epithelial surfaces such as the gastrointestinal mucosa depend on expression of antimicrobial peptides like
cathelicidin for immune defence against pathogens. The mechanisms behind mucosal cathelicidin regulation are
incompletely understood.
Methods: Cathelicidin expression was analysed in duodenal, antral and corpus/fundic mucosal biopsies from African and
German patients. Additionally, cathelicidin expression was correlated with Helicobacter pylori (HP) infection and the
inflammatory status of the mucosa.
Results: High cathelicidin transcript abundance was detected in duodenal biopsies from African subjects. On the contrary,
cathelicidin mRNA expression was either undetectable or very low in tissue specimens from German patients. Also, in the
antrum and corpus/fundus regions of the stomach significantly higher cathelicidin transcript levels were measured in
Tanzanian compared to German patients. In gastric biopsies from African patients cathelicidin expression was increased in
HP positive compared to HP negative subjects. Additionally, the inflammatory status measured by IL-8 expression correlated
well with the HP infection status.
Conclusions: A higher duodenal and gastric cathelicidin expression in African (compared with European) individuals may be
due to upregulation by antigenic stimulation and may confer a higher resistance against enteric infections.
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Introduction
The single cell layer of the colonic epithelium is an active
barrier against the external environment and the enormous load of
intestinal bacteria. In addition to forming a physical barrier, the
epithelium is armed with an array of effector molecules including
antimicrobial peptides [1]. These peptides can be considered as
endogenous antibiotics and are widespread in nature as immediate
defense effectors. They have been found in invertebrates,
vertebrates, plants as well as bacteria, and several human
antimicrobial peptides have been characterized [2].
The cathelicidins constitute a family of precursor proteins with a
well conserved cathelin pro-region, followed by a highly variable
C-terminal antimicrobial domain. The only human cathelicidin
gives rise to LL-37, a 37-residue mature antimicrobial peptide,
after cleavage from the cathelin propart. Both purified and
chemically synthesized LL-37 peptides exhibit potent and
comparable antimicrobial activities in vitro [3]. Antimicrobial
peptides are active effector molecules in intestinal mucosal defense
and constitute an integral part of immediate responses at epithelial
barriers [4].
There are few papers on LL-37 expression in the upper
gastrointestinal tract. In agreement with previous studies,
increased expression of hCAP-18/LL-37 was observed in gastric
mucosa obtained from Helicobacter pylori (HP) infected subjects
[5,6]. These authors concluded that cathelicidin contributes to
determining the balance between host mucosal defence and HP
survival mechanisms that govern chronic infection with this gastric
pathogen.
It was hypothesized that constant contact with enteric
pathogens in African patients might upregulate innate immunity
of the host. Thus, LL-37 expression was assessed in mucosal
biopsies from the duodenum, antrum, and corpus/fundus from
Tanzanian patients and compared with those of German patients
reporting for upper gastrointestinal endoscopy. Additionally,
cathelicidin expression was correlated with Helicobacter pylori
(HP) infection and the status of mucosal inflammation in African
individuals.
Results
High cathelicidin transcript abundance was detected in the
duodenal biopsies of African subjects. On the contrary, cathe-
licidin mRNA expression was either undetectable or very low in
tissue specimens from German patients (Fig. 1). In addition,
cathelicidin expression was also assessed in duodenal biopsies from
five German travellers who had recently returned from Africa with
diarrheal diseases (data not shown). Cathelicidin transcript levels
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history of overseas travel. Patient data are given in table 1.
To determine the cathelicidin transcript level in the antrum and
corpus/fundus regions we analyzed the gastric biopsies for LL37/
hCAP18 mRNA expression. As shown in Figure 2A/B we
measured significantly higher cathelicidin transcript levels in
Tanzanian than in German patients (Fig. 2).
In biopsies from African and German patients cathelicidin
expression was analysed in relation to helicobacter pylori (HP)
infection status: 19/27 african antral biopsies and 7/11 african
corpus or fundus biopsies tested positive for HP. In contrast only
1/10 german antral biopsies and 3/20 corpus or fundus biopsies
were tested positive for HP in Germany. As controls we also
assessed mRNA levels from IL8 and hBD2, which was upregulated
by mucosal inflammation. Figure 3A showed that cathelicidin,
hBD2 and IL8 mRNA levels were significantly increased in HP
positive compared with HP negative subjects. Figure 3B showed
the african corpus/fundus biopsies correlated with the HP
infections status. We could show that the IL8 as well as the
hBD2 expression level correlated well with the HP infection status.
Discussion
To protect the gastrointestinal tract, physical and chemical
barriers (e.g. the production of mucin) or innate immune
components of the blood (such as neutrophils, macrophages,
etc.) are important. In addition to these diverse strategies, the
active synthesis and secretion of small cationic peptides by the
epithelium and immune cells has become recognized as a key
mechanism for host defense. Antimicrobial peptides, e.g. defensins
and cathelicidins, are small proteins that are considered together
as a result of their antimicrobial activity but are in fact an
extremely diverse group of gene products. Antimicrobial peptides
participate in the innate immune system and are used by all
eukaryotic organisms studied to date, including plants, insects and
animals [7].
Cathelicidins are characterized by an N-terminal signal peptide,
the cathelin prosequence, and a structurally variable cationic
peptide at the C-terminus. The mature human cathelicidin is
referred to as LL-37 because it begins with two leucine residues
and is 37 amino acid residues long. Furthermore, the bactericidal
activity of the human cathelicidin peptide requires proteolytic
activation from its precursor. In-vitro studies using synthetic LL-37
show that this peptide has antimicrobial activity against Gram-
negative and Gram-positive bacteria, with susceptible strains such
as E. coli, P. aeruginosa, Klebsiella pneumoniae, Neisseria
gonorrhoeae and group A Streptococcus. LL-37 and LL-37
derived peptides are also active against gastrointestinal pathogens,
including several Helicobacter strains, Shigella, Salmonella and C.
albicans [8].
Human cathelicidin is expressed by epithelial cells lining the
stomach, lower small bowel and throughout the colon [9].
Expression is most prominent in the lower small intestine and
colon with high peptide abundance in superficial epithelial cells.
Nevertheless, except for butyrate, no microbial or inflammatory
stimulus could be identified as being responsible for cathelicidin
induction [10]. – High duodenal and gastric expression of
cathelicidin in African individuals is a new finding as the bulk of
available data has been obtained from subjects living in Europe or
North America. The underlying mechanism is unknown; it may be
speculated that constant exposure to enteric pathogens stimulates
the mucosa of the upper gastrointestinal tract to upregulate the
production of protective antimicrobial peptides and thus strength-
en the barrier. – The expression of a-defensins has been measured
in jejunal biopsies from Zambian adults; low mRNA levels were
related to susceptibility to intestinal infection [11]. This paper is to
our knowledge the only one in which data on innate immunity
have been reported in an African cohort and it must kept in mind
that this is a preliminary study that is applied to generate a
hypothesis and confounding variables will be considered in future
analysis.
Although the gastrointestinal tract is colonized by and exposed
to a multitude of different bacteria, intestinal infection or
translocation of bacterial agents is the exception, not the rule,
and is mostly limited to highly pathogenic bacteria or predisposing
disease states. Under normal conditions, the epithelial surface as
well as the mucus layer of the colon are nearly devoid of bacteria,
probably due to the constitutive epithelial synthesis of antimicro-
bial peptides. Evidence for a critical role for cathelicidin in
antimicrobial defense at the gastrointestinal mucosa also comes
from experimental animal models. Mice lacking cathelicidin are
Figure 1. Expression of cathelicidin mRNA in human duodenal
biopsies. Duodenal biopsies from 9 German and 12 African patients
were analyzed by real-time PCR for cathelicidin mRNA expression.
Levels are normalized to glyceraldehydes-3-phosphate dehydrogenase
(GAPDH). Data are expressed as ,fold change in mRNA transcript levels
relative to German subjects. Horizontal bars represent median
cathelicidin expression.
doi:10.1371/journal.pone.0022049.g001
Table 1. Clinical data of patients.
Wuerzburg
(Germany) Mwanza (Tanzania)
Age 57,1+21,3 years (SD) 43,2+14,6 years (SD)
Sex 15 male, 20 female 18 male, 12 female
Endoscopic findings hiatal hernia
reflux esophagitis
Barrett’s esophagus
gastric ulcer
gastritis
duodenal ulcer
PEG placement
no abnormality
hiatal hernia
reflux esophagitis
esophageal varices
gastric ulcer
gastric cancer
gastritis
duodenal ulcer
duodenitis
no abnormality
No. of biopsy sites:
Duodenum 10 12
Antrum 10 27
Corpus and fundus 15 11
doi:10.1371/journal.pone.0022049.t001
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Moreover, macrophages from cathelicidin deficient animals are
unable to fight intracellular Salmonella bacteria [12].
In humans, intestinal cathelicidin expression is altered during
infection, such as in the gastric mucosa during infection with H.
pylori [5]. The finding of elevated cathelicidin expression in the
presence of Helicobacter pylori is in line with the data of Hase
et al. [5]. Human cathelicidin is scarcely expressed in the upper
gastrointestinal tract of healthy Caucasians. These authors showed
that surface gastric epithelial cells and epithelial cells in the fundic
Figure 2. Expression of cathelicidin mRNA in biopsies from the stomach. (A) Biopsies from the antrum of 10 German and 27 African patients
were analyzed by real-time PCR for cathelicidin mRNA expression. (B) Biopsies from the corpus and fundus of 15 German and 11 African patients were
analyzed as described under (A). Levels are normalized to glyceraldehydes-3-phosphate dehydrogenase (GAPDH). Data are expressed as ,fold
change in mRNA transcript levels relative to German subjects. Horizontal bars represent median cathelicidin expression.
doi:10.1371/journal.pone.0022049.g002
Figure 3. Expression of cathelicidin mRNA, interleukin-8 (IL-8) and beta-defensin 2 (hbd2) in biopsies. From the gastric antrum (A) and
corpus/fundus (B) of African and German patients. Data were correlated with helicobacter pylori (HP) infection status. Levels are normalized to
glyceraldehydes-3-phosphate dehydrogenase (GAPDH). Data are expressed as ,fold change in mRNA transcript levels relative to German subjects.
Horizontal bars represent median cathelicidin expression. Cathelicidin and hbd2 levels were significantly increased in HP positive compared with HP
negative patients. The inflammatory status measured by IL-8 expression correlated well with the HP infection status.
doi:10.1371/journal.pone.0022049.g003
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into gastric secretions. Epithelial LL-37 expression is up-regulated
by HP infection but not by proinflammatory cytokines. Further-
more, LL-37 has significant antimicrobial activity against several
strains of HP. In agreement with recent studies our findings
suggest that increasing production of bacterial peptide LL-37 may
play a key role in host defence against HP. Leczczyn ´ska et al
conclude that increased expression of hCAP-18/LL-37 peptide in
gastric mucus of infected subjects may have additional functions as
an anti-inflammatory and growth stimulation agent. Alternatively,
loss of defense against HP may be due to loss of antibacterial
function of LL-37 in the milieu of gastric mucosa. In the antral
biopsies, expression levels of hBD2 mRNA in the HP group were
significantly increased in comparison to the non-HP group. LL37
and hBD2 have different bactericidal activity for HP. The various
bioactivities of LL37 and hBD2 may depend on factors, e.g.
differences in the membrane composition or structure of HP
compared with E. coli [5].
There is scarce information on the regulation of antimicrobial
peptides in the upper gastrointestinal tract. On the contrary, it is
known that cathelicidin peptide is regulated physiologically in the
colon by short-chain fatty acids such as butyrate [9]. Butyric acid is
produced by the resident colonic flora and represents a major
nutritional factor for colonocytes [13]. Consequently, in an
attempt to fight Shigella infection, Raqib et al. [14] suggested
that a disease such as shigellosis can be treated by stimulating the
colon epithelium with butyrate to produce cathelicidin. In this
landmark study, experimental dysentery was induced in rabbits
and once symptoms were noted, the animals received butyrate or
saline as a control. Significant benefit was observed from butyrate
administration, including improvement in clinical symptoms, less
blood in stool and reduction of bacterial counts in stools. These
data indicate that cathelicidin is an essential antimicrobial factor in
gastrointestinal epithelia and, for the first time, that therapeutic
induction of cathelicidin expression might offer an alternative
treatment option in the management of infectious disease of the
intestine.
In order to survive in the human gastrointestinal tract, many
bacterial pathogens have developed countermeasures to limit the
effectiveness of antimicrobial peptides. Islam et al. [15] observed
that Shigella can downregulate epithelial cathelicidin expression to
subsequently invade the mucosa. This effect is mediated by
plasmid DNA which is released from lysed Shigella dysenteria
bacteria and penetrates the epithelial cell lining. A high basal
expression level of antimicrobial peptides, as found in this study in
Tanzanian individuals, may possibly be protective against invasive
enteric organisms.
In conclusion, a better understanding of host defences will open
up new therapeutic strategies to fight bacterial and other
infections. The finding of higher duodenal and gastric cathelicidin
expression in African (compared with European) individuals may
explain a higher resistance against enteric infections and may
stimulate research into new treatment modalities.
Materials and Methods
Patient data
Patients admitted to the University Hospital, Wuerzburg
(Germany), and the Bugando Medical Centre, Mwanza (Tanza-
nia), underwent routine upper gastrointestinal endoscopy with
Olympus videoendoscopes (Wuerzburg) or fiberglass endoscopes
(Mwanza). The endoscopic examinations were performed for
various clinical reasons (tab.1); patients with diarrhea and
suspected small bowel disease were not included in the study. At
the University Hospital in Wuerzburg we included only German
patients without ethnic African background (tourist or people from
development aid programmes) in the study. Human studies were
approved by an amendmend to the local ethics committee
no. 104/00 (Medical Faculty, University of Wuerzburg, Ger-
many), and all participants gave written consent prior to
endoscopy. In Bugando/Tanzania informed consent was obtained
for endoscopy including biopsies for scientific purpose.
Biopsies were taken with a standard forceps from the
descending part of the duodenum, gastric antrum and corpus/
fundus. They were placed immediately in RNAlater medium
(Ambion, Austin, Texas) and kept at room temperature until
analysis within 4 weeks. Patient data are given in Tab. 1.
RNA preparation and reverse transcription
Biopsies from 65 patients (30 African, 35 German) were
disrupted in 1 ml RNAlater medium (Ambion, Austin, Texas)
until complete fragmentation as described previously [16]. Total
RNA was extracted according to the manufacturer’s RNA cleanup
protocol (RNeasy, QIAGEN, Germany). Residual DNA was
removed by on-column digestion during RNA purification with
QIAGEN RNase-free DNase (QIAGEN). The RNA concentra-
tion was quantified by determination of the absorbance at 260 and
280 nm, and RNA integrity was checked by visualization on a
1.5% agarose gel. Subsequently, 1 mg RNA was reverse tran-
scribed with iScript (BioRad, Hercules, California, USA).
Real-time RT-PCR assays
For quantification the expression of cathelicidin and the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were measured in triplicates by realtime RT-PCR
using a BioRad iCycler (BioRad, Hercules, California, USA).
Primers and fluorogenic probes for cathelicidin and GAPDH have
been described previously [2]. Cathelicidin and GAPDH expres-
sion was measured by Ct and corresponding transcript numbers
were read off standard curves as reported previously [9]. In
addition, IL8 expression levels were quantified in all African and
german patients using a Taqman real-time PCR assay (Applied
Biosystems, Foster City, California, USA). Hbd2 expression levels
were quantified using BDEFfor (5- GTATAATGTAAGGA-
AGGCGGGGAG-3) and BDEFrev (5- TCCTGGTTTCAA-
CCT CATTCTTCT-3) from MWG (Germany) and BDEF probe
(5–6FAM-ATGCTGCAAAAAG-MGBNFQ-3) from Applied
Biosystems. Since in real-time PCR there is no established
housekeeping gene for quantification of gene expression in biopsy
material from different mucosa, relative levels of cathelicidin and
IL8 transcription were calculated using two methods: gene
transcript numbers were normalized to the amount of total
RNA from Germany as recommended previously [9,17,18]; in
addition, gene expression levels were normalized to GAPDH
expression.
Analysis of Helicobacter infection status
Total cDNA of the biopsies was used as template DNA to PCR-
amplify the H. pylori 16 S rRNA gene. The PCR primers used are:
16S-5 GCTAAGAGATCAGCCTATGTCC and 16S-3 TGGC-
AATCAGCGTCAGGTAATG [19]. The resulting PCR product
was 520 bp and showed a positive HP infection status of the
patients.
Statistical analysis
All statistical analyses were performed using SigmaStat 2.03
(SPSS Inc., San Rafael, California, USA). Student’s paired t-test
Intestinal Cathelicidin Expression
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the Mann–Whitney rank sum test and the Kruskall–Wallis
ANOVA were used for statistical comparison of grouped patient
data. Differences were considered significant at p-values of 0.05 or
less.
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